Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Hachfeld, A; Darling, K; Calmy, A; Ledergerber, B; Weber, R; Battegay, M; Wissel, K; Di Benedetto, C; Fux, C A; Tarr, P E; Kouyos, R; Ruggia, L S; Furrer, H J; Wandeler, G; Swiss HIV Cohort Study (2019). Why do sub-Saharan Africans present late for HIV care in Switzerland? HIV Medicine, 20(6):418-423.

Aebi-Popp, K; Wandeler, G; Salazar-Vizcaya, L; Metzner, K; Stöckle, M; Cavassini, M; Hoffmann, M; Lüthi, A; Suter, F; Bernasconi, E; Fehr, Jan; Furrer, H; Rauch, A; Swiss HIV Cohort Study (2018). Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men. HIV Medicine, 19(6):420-425.

Salazar-Vizcaya, L; Kouyos, R D; Fehr, J; Braun, D; Estill, J; Bernasconi, E; Delaloye, J; Stöckle, M; Schmid, P; Rougemont, M; Wandeler, G; Günthard, H F; Keiser, O; Rauch, A; Swiss HIV Cohort Study (2018). On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study. Journal of Viral Hepatitis, 25(1):10-18.

Clifford, G M; Lise, M; Franceschi, S; Egger, M; Bouchardy, C; Korol, D; Levi, F; Ess, S; Jundt, G; Wandeler, G; Fehr, J; Schmid, P; Battegay, M; Bernasconi, E; Cavassini, M; Calmy, A; Keiser, O; Schöni-Affolter, F (2012). Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. British Journal of Cancer, 106(3):447-452.

Wandeler, G; Keiser, O; Hirschel, B; Günthard, H F; Bernasconi, E; Battegay, M; Clerc, O; Vernazza, P L; Furrer, H (2011). A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA. PLoS ONE, 6(12):e27903.

This list was generated on Thu Sep 19 10:30:54 2019 CEST.